Protek | Cash Flow

Fiscal year is January-December. All values RUB Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,018
4,793
10,970
6,113
5,880
6,380
Depreciation, Depletion & Amortization
862
828
917
1,097
1,475
1,796
Other Funds
52
2
1
1
3
379
Funds from Operations
3,313
5,201
9,874
9,386
7,857
8,710
Changes in Working Capital
1,627
1,559
3,817
335
2,994
18,784
Net Operating Cash Flow
1,686
94
223
145
83
438
Capital Expenditures
713
30
31
77
69
Sale of Fixed Assets & Businesses
12
13
25
84
218
Purchase/Sale of Investments
2,256
-
132
254
21
Net Investing Cash Flow
649
49
93
94
47
Cash Dividends Paid - Total
3,171
968
-
10,063
5,313
Issuance/Reduction of Debt, Net
27
6
8
4
45
Net Financing Cash Flow
3,291
50
29
112
139
Net Change in Cash
2,133
317
8,188
3,940
6,031
Free Cash Flow
973
64
192
68
15
Deferred Taxes & Investment Tax Credit
-
-
112
226
127
155
Net Assets from Acquisitions
-
-
-
-
873
Other Sources
5,360
3,342
7,909
16,698
4,004
Change in Capital Stock
41
17
21
43
-
Exchange Rate Effect
121
503
1,982
161
48
Other Uses
3,052
106
60
14
14

About Protek

View Profile
Address
2, ulica Chermyanskaya
Moscow MC 127282
Russian Federation
Employees -
Website http://www.protek-group.ru
Updated 07/08/2019
Protek PJSC distributes, manufactures and sales of pharmaceuticals, health and beauty care products. It operates through the following segments: Production, Distribution and Retail. The company was founded on November 21, 1990 and is headquartered in Moscow, Russia.